Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Zhou Y, Crowley RS, Ben K, Prisinzano TE, Kreek MJ.

Brain Res. 2017 May 1;1662:75-86. doi: 10.1016/j.brainres.2017.02.027. Epub 2017 Mar 2.

PMID:
28263712
2.

Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S.

Neuropharmacology. 2017 Feb;113(Pt A):281-292. doi: 10.1016/j.neuropharm.2016.10.011. Epub 2016 Oct 12.

PMID:
27743931
3.

Clerodane diterpenes: sources, structures, and biological activities.

Li R, Morris-Natschke SL, Lee KH.

Nat Prod Rep. 2016 Oct 28;33(10):1166-226. doi: 10.1039/c5np00137d. Epub 2016 Jul 18. Review.

4.

Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA Jr, Chartoff EH.

J Neurosci. 2016 May 25;36(21):5748-62. doi: 10.1523/JNEUROSCI.2875-12.2016.

5.

Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Taylor GT, Manzella F.

Curr Neuropharmacol. 2016;14(2):165-76. Review.

6.

The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Lutfy K, Zaveri NT.

Prog Mol Biol Transl Sci. 2016;137:149-81. doi: 10.1016/bs.pmbts.2015.10.003. Epub 2015 Dec 23. Review.

7.

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Chartoff EH, Mavrikaki M.

Front Neurosci. 2015 Dec 16;9:466. doi: 10.3389/fnins.2015.00466. eCollection 2015. Review.

8.

Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.

Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF.

Neuropsychopharmacology. 2016 Mar;41(4):989-1002. doi: 10.1038/npp.2015.226. Epub 2015 Aug 4.

9.

The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.

Fortin SM, Chartoff EH, Roitman MF.

Neuropsychopharmacology. 2016 Feb;41(3):906-15. doi: 10.1038/npp.2015.220. Epub 2015 Jul 27.

10.

Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area.

Yap JJ, Chartoff EH, Holly EN, Potter DN, Carlezon WA Jr, Miczek KA.

Psychopharmacology (Berl). 2015 May;232(9):1555-69. doi: 10.1007/s00213-014-3796-7. Epub 2014 Nov 6.

11.

Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats.

Bonano JS, Runyon SP, Hassler C, Glennon RA, Stevens Negus S.

Eur J Pharmacol. 2014 Nov 15;743:98-105. doi: 10.1016/j.ejphar.2014.09.006. Epub 2014 Sep 16.

12.

Drug withdrawal conceptualized as a stressor.

Chartoff EH, Carlezon WA Jr.

Behav Pharmacol. 2014 Sep;25(5-6):473-92. doi: 10.1097/FBP.0000000000000080. Review.

13.

Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.

Simonson B, Morani AS, Ewald AW, Walker L, Kumar N, Simpson D, Miller JH, Prisinzano TE, Kivell BM.

Br J Pharmacol. 2015 Jan;172(2):515-31. doi: 10.1111/bph.12692. Epub 2014 Jul 1.

14.

Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

Kivell BM, Ewald AW, Prisinzano TE.

Adv Pharmacol. 2014;69:481-511. doi: 10.1016/B978-0-12-420118-7.00012-3. Review.

15.

Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Robles CF, McMackin MZ, Campi KL, Doig IE, Takahashi EY, Pride MC, Trainor BC.

Behav Brain Res. 2014 Apr 1;262:84-93. doi: 10.1016/j.bbr.2014.01.003. Epub 2014 Jan 18.

16.

The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.

Morani AS, Ewald A, Prevatt-Smith KM, Prisinzano TE, Kivell BM.

Eur J Pharmacol. 2013 Nov 15;720(1-3):69-76. doi: 10.1016/j.ejphar.2013.10.050. Epub 2013 Nov 4.

17.

Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats.

Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH.

Biol Psychiatry. 2014 Aug 1;76(3):213-22. doi: 10.1016/j.biopsych.2013.07.042. Epub 2013 Oct 3.

18.

Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction.

Kallupi M, Wee S, Edwards S, Whitfield TW Jr, Oleata CS, Luu G, Schmeichel BE, Koob GF, Roberto M.

Biol Psychiatry. 2013 Oct 1;74(7):520-8. doi: 10.1016/j.biopsych.2013.04.028. Epub 2013 Jun 14.

19.

A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.

Morani AS, Schenk S, Prisinzano TE, Kivell BM.

Behav Pharmacol. 2012 Apr;23(2):162-70. doi: 10.1097/FBP.0b013e3283512c1e.

20.

Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats.

Negus SS, O'Connell R, Morrissey E, Cheng K, Rice KC.

J Pharmacol Exp Ther. 2012 Mar;340(3):501-9. doi: 10.1124/jpet.111.186783. Epub 2011 Nov 29.

Supplemental Content

Support Center